A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

NCT03525873 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Neoplasm
Metastatic Malignant Neoplasm
Recurrent Malignant Neoplasm

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Methylphenidate
OTHER: Physical Activity
OTHER: Placebo
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]